Detalhe da pesquisa
1.
Rational use of rasburicase for the treatment and management of tumor lysis syndrome.
J Oncol Pharm Pract
; 24(3): 176-184, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077046
2.
Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.
Support Care Cancer
; 23(8): 2287-95, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25576429
3.
Financial Impact of an Automated Oncology Dose-Rounding Initiative: One-Year Analysis.
JCO Clin Cancer Inform
; 5: 805-810, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351786
4.
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor.
Onco Targets Ther
; 9: 2783-93, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27274274